MYCOBACTERIUM TUBERCULOSIS BACTERIOLOGICALLY
CONFIRMED NEW CASES & RESISTANCE RATES
(1995-2017)
|
YEAR |
NEW CASES (TOTAL) No |
NEW CASES (GREEKS) No (%) |
NEW CASES (FOREIGN-BORN) No (%) |
RES INH [ANY] (GREEKS) No (%) |
RES INH [ANY] (FOREIGN-BORN) No (%) |
RES [ANY] (GREEKS) No (%) |
RES [ANY] (FOREIGN-BORN) No (%) |
MDR (GREEKS) No (%) |
MDR (FOREIGN-BORN) No (%) |
|
1995 |
320 |
280 (87.5) |
40 (12.5) |
16 (5.7) |
6 (17.5) |
6 (2.1) |
2 (5.7) |
3 (1.0) |
2 (5.7) |
|
1996 |
336 |
283 (84.2) |
53 (15.8) |
15 (5.3) |
9 (15.7) |
3 (1.0) |
2 (4.8) |
2 (0.7) |
2 (4.8) |
|
1997 |
344 |
294 (85.5) |
50 (14.5) |
22 (7.5) |
23 (50.4) |
7 (2.4) |
10 (21.3) |
6 (2.0) |
11 (24.5) |
|
1998 |
410 |
304 (74.1) |
106 (25.9) |
25 (8.2) |
14 (13.2) |
8 (2.6) |
7 (6.6) |
6 (2.0) |
7 (6.6) |
|
1999 |
545 |
452 (82.9) |
93 (17.1) |
34 (7.5) |
16 (17.2) |
23 (5.1) |
11 (11.8) |
22 (4.9) |
10 (10.8) |
|
2000 |
650 |
535 (82.3) |
115 (17.7) |
26 (4.9) |
9 (7.8) |
20 (3.7) |
3 (2.6) |
17 (3.2) |
3 (2.6) |
|
2001 |
628 |
491 (78.2) |
137 (21.8) |
38 (7.7) |
12 (8.8) |
10 (2.0) |
4 (2.9) |
10 (2.0) |
3 (2.2) |
|
2002 |
520 |
362 (69.6) |
158 (30.4) |
27 (7.5) |
13 (8.2) |
13 (3.6) |
11 (7.0) |
12 (3.3) |
8 (5.1) |
|
2003 |
540 |
387 (71.7) |
153 (28.3) |
42 (10.8) |
23 (15.0) |
20 (5.2) |
10 (6.5) |
15 (3.9) |
6 (3.9) |
|
2004 |
460 |
282 (61.3) |
178 (38.7) |
35 (12.4) |
20 (11.2) |
12 (4.3) |
7 (3.9) |
7 (2.5) |
7 (3.9) |
|
2005 |
497 |
319 (64.2) |
178 (35.8) |
20 (6.3) |
12 (6.7) |
13 (4.1) |
10 (5.6) |
9 (2.8) |
6 (3.4) |
|
2006 |
466 |
312 (67.0) |
154 (33.0) |
12 (3.8) |
10 (6.5) |
7 (2.2) |
12 (7.8) |
4 (1.3) |
9 (5.8) |
|
2007 |
454 |
262 (57.7) |
192 (42.3) |
9 (3.4) |
25 (13.0) |
4 (1.5) |
14 (7.3) |
1 (0.4) |
12 (6.3) |
|
2008 |
431 |
245 (56.8) |
186 (43.2) |
25 (10.2) |
15 (8.1) |
8 (3.2) |
6 (3.2) |
8 (3.2) |
5 (2.7) |
|
2009 |
441 |
201 (45.6) |
240οΏ½ (54.4) |
7 (3.4) |
19 (7.9) |
4 (1.9) |
12 (5.0) |
4 (1.9) |
11 (4.6) |
|
2010 |
461 |
154 (33.4) |
307 (66.6) |
8 (5.2) |
18 (5.9) |
3 (1.9) |
9 (2.9) |
3 (1.9) |
8
(2.6) |
|
2011 |
444 |
174 (39.2) |
270 (60.8) |
8 (4.6) |
28 (10.4) |
4 (2.3) |
13 (4.8) |
3 (1.7) |
13 (4.8) |
|
2012 |
422 |
197 (47) |
225 (53) |
20 (10.1) |
19 (8.4) |
4 (2) |
7 (3.1) |
4 (2) |
7
(3.1) |
|
2013 |
371 |
204 (55) |
167 (45) |
8 (4) |
25 (15) |
4 (1.7) |
16 (9.6) |
3 (1.5) |
15 (9) |
|
2014 |
321 |
170 (53) |
151 (47) |
11 (6.5) |
14 (9.3) |
1 (0.6) |
9 (6) |
1 (0.6) |
9 (6) |
|
2015 |
338 |
213 (63) |
125 (37) |
10 (4.7) |
14 (11.2) |
5 (2.3) |
8 (6.4) |
5 (2.3) |
8 (6.4) |
|
2016 |
296 |
170 (57) |
126 (43) |
4 (2.4) |
6 (4.8) |
3 (1.8) |
4 (1.3) |
2 (1.2) |
3 (2.4) |
|
2017 |
274 |
138 (50.4) |
136 (49.6) |
12 (8.7) |
17 (12.5) |
5 (3.6) |
6 (14.4) |
4 (2.9) |
4 (2.9) |
|
Total |
9969 |
6429 (64.5 ) |
3540 (35.5) |
435 (6.8) |
367 (10.3) |
187 (2.9) |
193 (5.5) |
151 (2.3) |
169 (4.8) |
Data from the Microbiology Department
οΏ½ National Reference Laboratory for Mycobacteria,
MDR vs.XDR Mycobacterium tuberculosis among Native Greeks and
Foreign-born
(2006-2017)
|
YEAR |
MTB NoοΏ½ (%) |
MDR No (%) |
XDR No (%) |
XDR/MDR (%) |
||||||||
|
|
TOTAL |
GREEKS |
FOREIGN-BORN |
TOTAL |
GREEKS |
FOREIGN-BORN |
TOTAL |
GREEKS |
FOREIGN-BORN |
TOTAL |
GREEKS |
FOREIGN-BORN |
|
2006 |
466 |
312 οΏ½(67) |
154 (33) |
13 (2.8) |
4 (1.3) |
9 (5.8) |
1 (0.2) |
1 (1.3) |
0 (0) |
9.1 |
25 |
0 |
|
2007 |
454 |
262 (57.7) |
192 (42.3) |
13 (2.86) |
1 (0.4) |
12 (6.3) |
0 (0) |
0 (0) |
0 (0) |
οΏ½22.5 |
0 |
0 |
|
2008 |
431 |
245 (56.8) |
186 (43.2) |
13 (3) |
8 (3.2) |
5 (2.7) |
4 (0.9) |
2 (0.8) |
2 (1.1) |
30.7 |
25 |
40 |
|
2009 |
441 |
201 (45.6) |
240 (54.4) |
15 (3.4) |
4 (1.9) |
11 (4.6) |
2 (0.5) |
2 (1) |
0 (0) |
13.3 |
50 |
0 |
|
2010 |
461 |
154 (33.4) |
307 (66.6) |
11 (2.4) |
3
(1.9) |
8
(2.6) |
5 (1.1) |
0 (0) |
5 (1.6) |
45.5 |
0 |
62.5 |
|
2011 |
444 |
174 (39.2) |
270 (60.8) |
16 (3.6) |
3 (1.7) |
13 (4.8) |
4 (0.9) |
0 (0) |
4 (1.5) |
25 |
0 |
30.7 |
|
2012 |
422 |
197 (47) |
225 (53) |
11 (2.6) |
4 (2) |
7
(3.1) |
1 (0.2) |
0 (0) |
1 (0.4) |
9 |
0 |
14.3 |
|
2013 |
371 |
204 (55) |
167 (45) |
18 (4.9) |
3 (1.5) |
15 (9) |
1 (0.3) |
0 (0) |
0 (0) |
5.5 |
0 |
0 |
|
2014 |
321 |
170
(53) |
151
(47) |
10 (3.1) |
1
(0.6) |
9 (6) |
3 (0.9) |
0 (0) |
3 (0.9) |
30 |
0 |
33.3 |
|
2015 |
338 |
213 (63) |
125 (37) |
13 (3.8) |
5 (2.3) |
8 (6.4) |
0 (0) |
0 (0) |
0 (0) |
0 |
0 |
0 |
|
2016 |
296 |
170 (57) |
126 (43) |
5 (1.7) |
2 (1.2) |
3 (2.4) |
0 (0) |
0 (0) |
0 (0) |
0 |
0 |
0 |
|
2017 |
274 |
138 (50.4) |
136 (49.6) |
8 (2.9) |
4 (2.9) |
4 (2.9) |
1 (0.4) |
1 (0.4) |
0 (0) |
12.5 |
25 |
0 |
|
TOTAL (2006-2017) |
4719 |
2440 (52) |
2279 (48) |
136 (2.9) |
42 (31) |
94 (69) |
21 (0.4) |
6 (29) |
15 (71) |
15.5 |
14.3 |
16 |
Data from the Microbiology
Department οΏ½ National Reference Laboratory for Mycobacteria,
Bacteriologically
confirmed new tuberculosis cases among
Native Greeks
and Foreign-born
(1995-2017)
Data from the Microbiology
Department οΏ½ National Reference Laboratory for Mycobacteria,
Any Resistance (%) to Isoniazid (INH), Rifampicin (
Multidrug Resistance (MDR)
among Native Greeks
(1995-2017)
Data from the Microbiology
Department οΏ½ National Reference Laboratory for Mycobacteria,
Any Resistance (%) to Isoniazid (INH), Rifampicin (
Multidrug Resistance (MDR)
among Foreign-born
(1995-2017)
Data from the Microbiology
Department οΏ½ National Reference Laboratory for Mycobacteria, Sotiria Chest
Diseases Hospital, Athens
οΏ½
2018οΏ½οΏ½οΏ½ Last
modified by D.
Papaventsis:οΏ½
March 2018